BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Jun 24, 2013
 |  BC Week In Review  |  Clinical News  |  Clinical Results

NKTR-181 neurology data

Top-line data from a double-blind, 5-way crossover human abuse liability trial in 42 recreational drug users showed that all doses of oral NKTR-181 had significantly lower "drug liking," "feeling high" and sleepiness scores compared to oxycodone (p<0.0001 for all). NKTR-181 had similar scores on the "drug liking" and...

Read the full 218 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >